Clinical trial
Phase 3 Randomized, Double-Blind Placebo-Controlled, Multicenter, Parallel-Group, Repeated-Dose Study of the Analgesic Efficacy & Safety of IV Acetaminophen Versus Placebo for the Treatment of Postop Pain
NCT00564486 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3 Randomized, Double-Blind Placebo-Controlled, Multicenter, Parallel-Group, Repeated-Dose Study of the Analgesic Efficacy & Safety of IV Acetaminophen Versus Placebo for the Treatment of Postop Pain
- Lead sponsor
- Mallinckrodt
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- September 30, 2008
- Enrollment
- 244 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.